Voriconazole hepatotoxicity as a result of steroid withdrawal in a patient with allergic bronchopulmonary aspergillosis
Open Access
- 9 December 2018
- journal article
- letter
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 85 (2) , 460-462
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicityInternational Journal of Antimicrobial Agents, 2014
- CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interactionExpert Opinion on Drug Metabolism & Toxicology, 2014
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug MonitoringAntimicrobial Agents and Chemotherapy, 2012
- Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal InfectionsClinical Infectious Diseases, 2012
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in PatientsAntimicrobial Agents and Chemotherapy, 2011
- Case Definition and Phenotype Standardization in Drug-Induced Liver InjuryClinical Pharmacology & Therapeutics, 2011
- Proposal for a New Tool to Evaluate Drug Interaction CasesAnnals of Pharmacotherapy, 2007
- Pharmacokinetic/Pharmacodynamic Profile of VoriconazoleClinical Pharmacokinetics, 2006
- Identification of Constitutive Androstane Receptor and Glucocorticoid Receptor Binding Sites in the CYP2C19 PromoterMolecular Pharmacology, 2003